Abstract:Introduction: Gitelman syndrome(GS) is a rare inherited tubular disorder which is characterized by hypokalemia, metabolic alkalosis, hypomagnesemia, and hypocalciuria. Here, we report a case of schizophrenia-like psychosis concomitant with GS and related literatures are reviewed.Case description: An 18-year-old male patient with 1-week history of auditory hallucinations, sense of insecurity, delusions of reference and feelings of being followed and controlled by others unknown, insomnia was admitted to Psychiatry department in December, 2013. Hypokalemia and hypomagnesemia were noted. He was diagnosed as schizophrenia-like psychosis. Treatment with paliperidone at the dose of 6 mg/day and magnesium and potassium supplementations was commenced. However, electrolyte disturbances failed to improve following psychosis remission. Therefore, other underlying diseases resulting in electrolyte disturbances were suspected. Along with hypokalemia and hypomagnesemia, additional investigation showing metabolic alkalosis, hypocalciuria, renal loss of potassium, were consistent with GS. Gene analysis revealed this patient carried out c. 2687 G > A homozygous mutation of exon 23 in the SLC12A3 gene which led to p.Arg896Gln. Eventually, GS was identified. Thus, additional spironolactone (40 mg/day) combined with increased doses of oral potassium chloride sustained-release tablets (3.0 g/day) and potassium magnesium aspartate (0.3 g/day) were administered. During next half a year, fatigue resolved, paliperidone gradually tapered and eventually discontinued while psychosis maintained complete remission. His serum potassium was near normal (3.2-3.5 mmol/L), hypomagnesemia significantly improved (0.57-0.67 mmol/L).Discussion and evaluation: Electrolyte abnormalities secondary to GS might cause or contribute to development of neuropsychiatric symptoms. In turn, hypokalemia was common among acute psychiatric inpatients. As a consequence, when concomitant with psychosis, GS was readily concealed.Conclusion: Electrolyte disturbances are common in acute psychiatric patients. However, when electrolyte disturbances are not improved following psychosis remission, other underlying diseases such as GS should be considered.

Proton pump inhibitor-induced hypomagnesemia, a rare cause of reversible delirium: A case report with literature review

Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature

Proton Pump Inhibitor Induced Hypomagnesemia Causing Seizures: A Rare Adverse Effect of a Commonly Used Medication

A Case of Severe Proton Pump Inhibitor-Induced Hypomagnesemia Refractory to Continuous Oral and Intravenous Magnesium Replenishment

Hypomagnesaemia - One Cause To Remember!

Proton-pump inhibitor use amongst patients with severe hypomagnesemia

Severe Hypomagnesemia Caused by Proton-Pump Inhibitors in a Patient With an Ostomy

Extrapontine Myelinolysis Associated with Pituitrin: Case Report and Literature Review

Seizure and Takotsubo Cardiomyopathy Due to Proton Pump Inhibitor

Schizophrenia-like Psychosis and Gitelman Syndrome: a Case Report and Literature Review.

Mechanisms of Proton Pump Inhibitor‐induced Hypomagnesemia

Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia

Hypomagnesaemia leading to parathyroid dysfunction, hypocalcaemia, and hypokalaemia as a complication of long-term treatment with a proton pump inhibitor — a literature review

Current situation of progress in long-term use of proton pump inhibitors may increase the risk of dementia

Association between exposure to proton pump inhibitors and delirium: a descriptive and disproportionality analysis of VigiBase

Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients

Proton pump inhibitors, bone and phosphocalcic metabolism

Proton pump inhibitors-induced psychiatric symptoms

Proton Pump Inhibitors Directly Block hERG-potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US Veterans

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H2 Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis

Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes